Skip to content

Clinical trials

Aspergillosis, Allergic Bronchopulmonary trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Aspergillosis, Allergic Bronchopulmonary Country / region: United Kingdom Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20161
20171
20191
20202
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Pulmatrix Inc.2
Community Pharmacology Services Ltd1
GlaxoSmithKline1
Regeneron Pharmaceuticals1
Scynexis, Inc.1
Zambon SpA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Aspergillosis, Allergic Bronchopulmonary9
Asthma3
Cystic Fibrosis2
Anemia1
Aspergillosis1
Blastomycosis1
Candidiasis, Chronic Mucocutaneous1
Candidiasis, Invasive1
Candidiasis, Vulvovaginal1
Coccidioidomycosis1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.